Ignite Creation Date:
2024-05-06 @ 7:22 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT05998447
Status:
RECRUITING
Last Update Posted:
2024-03-21
First Post:
2023-08-01
Brief Title:
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
Sponsor:
Organization:
Genome Company